| Dr Mark Geoffery Grossman, MD | |
|
1300 Franklin Ave, Suite Ul3a, Garden City, NY 11530-1886 | |
| (516) 747-8900 | |
| (516) 663-8124 |
| Full Name | Dr Mark Geoffery Grossman |
|---|---|
| Gender | Male |
| Speciality | Sports Medicine |
| Experience | 32 Years |
| Location | 1300 Franklin Ave, Garden City, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063402014 | NPI | - | NPPES |
| 02359162 | Medicaid | NY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | 224563 (New York) | Secondary |
| 207XX0005X | Orthopaedic Surgery - Sports Medicine | 224563 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| New York University Langone Medical Center | New york, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| New York University | 1355232422 | 4431 |
News Archive
Most attempts to develop imaging agents that can better distinguish tumors from healthy tissue focus on finding molecules that are more abundant on malignant cells than on normal cells and using those as cellular targets.
A team of researchers from Johns Hopkins Children's Center, the University of Mississippi Medical Center and the University of Massachusetts Medical School describe the first case of a so-called "functional cure" in an HIV-infected infant. The finding, the investigators say, may help pave the way to eliminating HIV infection in children.
Presage Biosciences, a leader in identifying clinically viable oncology drug combinations, today announced that it has entered into a cancer research agreement with Millennium: The Takeda Oncology Company.
A new study has made some worrying revelations about people who have heart attacks.
› Verified 8 days ago
| Entity Name | New York University |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285826438 PECOS PAC ID: 1355232422 Enrollment ID: O20081202000185 |
News Archive
Most attempts to develop imaging agents that can better distinguish tumors from healthy tissue focus on finding molecules that are more abundant on malignant cells than on normal cells and using those as cellular targets.
A team of researchers from Johns Hopkins Children's Center, the University of Mississippi Medical Center and the University of Massachusetts Medical School describe the first case of a so-called "functional cure" in an HIV-infected infant. The finding, the investigators say, may help pave the way to eliminating HIV infection in children.
Presage Biosciences, a leader in identifying clinically viable oncology drug combinations, today announced that it has entered into a cancer research agreement with Millennium: The Takeda Oncology Company.
A new study has made some worrying revelations about people who have heart attacks.
› Verified 8 days ago
| Entity Name | New York University |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285826438 PECOS PAC ID: 1355232422 Enrollment ID: O20090822000026 |
News Archive
Most attempts to develop imaging agents that can better distinguish tumors from healthy tissue focus on finding molecules that are more abundant on malignant cells than on normal cells and using those as cellular targets.
A team of researchers from Johns Hopkins Children's Center, the University of Mississippi Medical Center and the University of Massachusetts Medical School describe the first case of a so-called "functional cure" in an HIV-infected infant. The finding, the investigators say, may help pave the way to eliminating HIV infection in children.
Presage Biosciences, a leader in identifying clinically viable oncology drug combinations, today announced that it has entered into a cancer research agreement with Millennium: The Takeda Oncology Company.
A new study has made some worrying revelations about people who have heart attacks.
› Verified 8 days ago
| Entity Name | Winthrop Community Medical Affiliates Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457873077 PECOS PAC ID: 5698092385 Enrollment ID: O20150317001669 |
News Archive
Most attempts to develop imaging agents that can better distinguish tumors from healthy tissue focus on finding molecules that are more abundant on malignant cells than on normal cells and using those as cellular targets.
A team of researchers from Johns Hopkins Children's Center, the University of Mississippi Medical Center and the University of Massachusetts Medical School describe the first case of a so-called "functional cure" in an HIV-infected infant. The finding, the investigators say, may help pave the way to eliminating HIV infection in children.
Presage Biosciences, a leader in identifying clinically viable oncology drug combinations, today announced that it has entered into a cancer research agreement with Millennium: The Takeda Oncology Company.
A new study has made some worrying revelations about people who have heart attacks.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Mark Geoffery Grossman, MD 1300 Franklin Ave, Suite Ul3a, Garden City, NY 11530-1886 Ph: (516) 747-8900 | Dr Mark Geoffery Grossman, MD 1300 Franklin Ave, Suite Ul3a, Garden City, NY 11530-1886 Ph: (516) 747-8900 |
News Archive
Most attempts to develop imaging agents that can better distinguish tumors from healthy tissue focus on finding molecules that are more abundant on malignant cells than on normal cells and using those as cellular targets.
A team of researchers from Johns Hopkins Children's Center, the University of Mississippi Medical Center and the University of Massachusetts Medical School describe the first case of a so-called "functional cure" in an HIV-infected infant. The finding, the investigators say, may help pave the way to eliminating HIV infection in children.
Presage Biosciences, a leader in identifying clinically viable oncology drug combinations, today announced that it has entered into a cancer research agreement with Millennium: The Takeda Oncology Company.
A new study has made some worrying revelations about people who have heart attacks.
› Verified 8 days ago
Dr. Randy Marc Cohn, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1001 Franklin Avenue, Suite 110, Garden City, NY 11530 Phone: 516-396-7846 Fax: 516-281-7417 | |
Moiz Ismail Manaqib, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1101 Stewart Avenue, Suite 100 North, Garden City, NY 11530 Phone: 516-302-8180 Fax: 516-992-4637 | |
Dr. Ioannis Christos Zouzias, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1300 Franklin Ave, Suite Ul3a, Garden City, NY 11530 Phone: 516-747-8900 | |
Dr. Frank Rosario Dimaio, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 877 Stewart Ave, Suite 1, Garden City, NY 11530 Phone: 516-325-7310 Fax: 516-325-7311 | |
Minhal Mahmood, Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 877 Stewart Ave Ste 1, Garden City, NY 11530 Phone: 516-325-7310 | |
Omid S Barzideh, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1300 Franklin Ave, Suite Ul3a, Garden City, NY 11530 Phone: 516-747-8900 Fax: 516-663-3015 |